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Maintenance of the cellular redox balance has vital importance for correcting organism functioning. Methionine sulfoxide
reductases (Msrs) are among the key members of the cellular antioxidant defence system. To work properly, methionine sulfoxide
reductases need to be reduced by their biological partner, thioredoxin (Trx). This process, according to the available kinetic data,
represents the slowest step in the Msrs catalytic cycle. In the present paper, we investigated structural aspects of the intermolecular
complexformationbetweenmammalianMsrB1andTrx.NMRspectroscopyandbiocomputingwerethetwomostlyusedthrough
the research approaches. The formation of NMR detectable MsrB1/Trx complex was monitored and studied in attempt to
understand MsrB1 reduction mechanism. Using NMR data, molecular mechanics, protein docking, and molecular dynamics
simulations, it was found that intermediate MsrB1/Trx complex is stabilized by interprotein β-layer. The complex formation
accompanied by distortion of disulﬁde bond within MsrB1 facilitates the reduction of oxidized MsrB1 as it is evidenced by the
obtained data.
1.Introduction
Oxygen is vital for all aerobic biological processes. However,
a b o u t5 %o fi ti sc o n v e r t e di n t or e a c t i v eo x y g e ns p e c i e s
(ROS) [1]. Methionine residues in proteins are susceptible
to oxidation by reactive oxygen and nitrogen species leading
to formation of methionine sulfoxide (MetSO). This modi-
ﬁcation can result in loss of proteins’ function [2]. Organ-
isms developed a complex antioxidant defence system that
includes enzymatic and nonenzymatic antioxidants [3–5].
Methionine sulfoxide reductases (Msrs) are redox repairing
enzymes which reduce MetSO back to methionine (Met). A
number of published reports describe the role of methio-
nine sulfoxide reductases in antioxidant defence and the
regulation of protein function [6–10]. Methionine sulfoxide
reductases reduce both free and protein-bound MetSO, back
to Met in the presence of thioredoxin (Trx). Two distinct
families constitute Msrs: MsrA, which speciﬁcally reduces S-
epimer, and MsrB, which is stereospeciﬁc for R-epimer of
methionine sulfoxide [11–14].
Mammalian MsrB enzymes constitute three diﬀerent
subclasses: MsrB1, MsrB2, and MsrB3 [15–20]. All of them
contain Zn2+ ion, coordinated by two motifs CxxC (two
cysteines separated by two residues), which stabilize their
structure. Whereas mammalian MsrB1 contains a resolving
cysteine (Cys4) and catalytic selenocysteine (Sec95) in its
active site, the other two subclasses, MsrB2 and MsrB3, in
analogy with bacterial MsrBs, contain only catalytic cysteine
[21–24]. NMR solution [25] and X-ray crystal (PDB entry2 Journal of Biomedicine and Biotechnology
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3MAO) structures of mammalian MsrB1 have recently been
determined.
Reduction of methionine sulfoxide by selenocysteine
containing MsrB1 is a multistep process [24, 25]. First, a
catalytic Sec95 attacks a sulfoxide moiety of the substrate,
MetSO, resulting in the formation of selenenic acid inter-
mediate and concomitant release of methionine. Second,
a resolving Cys4 attacks the selenenic acid intermediate to
form an intramolecular selenide-sulﬁde bond, and ﬁnally, a
fullyreducedenzymeisregeneratedbyreductionofthelatter
bond with thioredoxin, a natural electron donor (Scheme 1).
It has been established that thioredoxin is the natural re-
ducing agent for the members of Msr family, though DTT
can be used as the reductant in vitro [14, 24, 26]. Reduction
of oxidized MsrB2 and MsrB3 as well as of the most bac-
terial MsrBs occurs through a similar mechanism without
formation of the intramolecular disulﬁde bridge. However, it
was reported that bacterial MsrB from Neisseria meningitides
upon oxidation form intramolecular disulﬁde bridge [27].
It was shown that its reduction by Trx is overall rate-limit-
ing step of MsrB cycle and it is described as an apparent
irreversible process.
Thioredoxin is a ubiquitous protein that plays an impor-
tant role in maintaining redox balance in cells [28]. In most
of its reactions, Trx reduces substrate disulﬁde bond. The
proposed mechanism of Trx-catalysed substrate disulﬁde
reduction [29–31] includes nucleophilic attack by thiolate
of Cys32 supported by hydrophobic interactions resulting in
transient mixed disulﬁde formation followed by nucleophilic
attack of the resolving Cys35 generating Trx-S2 and reduced
protein.
Summarising, reduction of MsrBs (mammalian and bac-
terial) disulﬁde bond by Trx, can be described by the fol-
lowing steps. First, thioredoxin and MsrB form an intermo-
lecular complex. In the second step, the just-formed inter-
molecular bond gets resolved by the thioredoxin resolving
cysteine 35, followed by the formation of reduced MsrB
and oxidized Trx. Subsequently, the S–S bridge of oxidized
thioredoxin is further reduced by NADPH and the speciﬁc
FAD-containing enzyme thioredoxin reductase. Some stud-
ies suggest that speciﬁc structural recognitions exist between
oxidized substrate disulﬁde bond and reduced Trx [14, 32].
The knowledge of the structure aspects of the MsrB/Trx
complex formation would help to understand full catalytic
mechanism of methionine sulfoxide reductases.
Here, we have investigated the structural aspects of the
interaction between mammalian oxidized MsrB1 and re-
duced thioredoxin. Mutants of MsrB1 and Trx were pro-
duced in order to get an intermolecular complex suitable
for its investigation using NMR spectroscopy. Firstly, since
Sec-containing MsrB1 is not possible to express in bacterial
cells, Sec95 of MsrB1 was replaced by Cys giving Sec95Cys
mutant (hereafter MsrB1). Further, thioredoxin containing
a Cys35Ser mutation (hereafter Trx) was obtained as this
modiﬁcation removes the second resolving Cys35 leading
to the formation of a detectable intermediate MsrB1-Trx
(Scheme 2). The resultant MsrB1-Trx complex is stable
and could, therefore, be structurally characterized by NMR
spectroscopy and with the aid of computational approach.
2.MaterialsandMethods
2.1. Microorganisms and Plasmids. The genes of C-terminal
his-tagged mouse MsrB1 (Sec95Cys) and human Trx
(Cys35Ser) mutants, cloned into pET21 expression vectors
were kindly provided by Professor V. Gladyshev’s group.
Escherichia coli strains ER2566 (New England Biolabs) and
BL21 (DE3) (Novagen) cells were respectively transformed
with the constructs using the standard protocol [33]. The
transformed cells were spread on several LB agar plates con-
taining 100mg/L of ampicillin and were further stored at
4◦C.
2.2. Protein Expression, Puriﬁcation, and Sample Preparation.
E. coli BL21(DE3) cells carrying plasmid pET21-Trx and
E. coli ER2566 cells containing pET21-MsrB1 were grown
in LB-media with 100mg/L ampicillin. To uniformly label
proteins either with 15No rw i t h15N-13C, cells were grown inJournal of Biomedicine and Biotechnology 3
M9minimalmediacontaining1g/L99%-enriched 15NH4Cl,
4g/L 13C6-glucose and 100mg/L of ampicillin. MsrB1 and
Trx were expressed, by growing host cells at 37◦C until
an OD600 reached 0.8, followed by induction of protein
synthesiswith1mMIPTGandsubsequentincubationfor3h
at37◦C.Cellswereharvestedbycentrifugationanddisrupted
bysonicationin50mMphosphatebuﬀer,pH8.0,containing
400mMNaCl, 0.01% Tween 20 (Sigma Aldrich); 5mM
β-mercaptoethanol as well as complete protease inhibitor
cocktail (Roche) (1 tab for 50mL).
Cell extract was clariﬁed by centrifugation and ﬁltering
through 0,45μm ﬁlter. Clear supernatant was loaded onto
the preequilibrated in binding buﬀer (50mMNa phosphate
buﬀer, pH 8.0, 400mMNaCl, 5mM β-mercaptoethanol,
and 5mM imidazole) Ni-NTA column (Novagen). The
column was step-washed with the increasing concentration
of imidazole (5, 10, and 20mM) in binding buﬀer followed
by elution of protein with 250mM imidazole in binding
buﬀer. The purity of the samples was examined with SDS-
PAGE gel (Invitrogen). The yield of the proteins per liter of
growth medium was 20mg and 10mg for MsrB1 and Trx,
respectively.
The obtained reduced MsrB1 was further subjected to
oxidation by excess of dabsyl-Met-R-SO (kindly provided by
Professor H-Y. Kim) for 3h at 25◦C in 20mM phosphate
buﬀer, 20mM NaCl, and pH 7.5. The ﬁnal NMR MsrB1ox
and Trxred samples contained 1,5–2mM of protein in 10mM
NaCl, 10mM phosphate, pH 5.5, 90%H2O, 10% D2Ob u ﬀer.
The sample for the backbone assignment of reduced double
enriched Trx (15N- and 13C) also contained 5mM DTT.
2.3. NMR Spectroscopy. All NMR spectra were recorded
a t2 9 8 Ke i t h e ro nB r u k e rA v a n c e6 0 0 M H zs p e c t r o m e t e r ,
equipped with 5mm z-gradients TXI (H/C/N) cryoprobe at
the NMR centre of NT faculty, NTNU or Varian DirectDrive
NMR System 700MHz spectrometer, equipped with 5mm
z-gradients salt tolerant H/C/N probe at the SPbSPU. Proton
chemicalshiftswerereferencedtoexternal3-(trimethylsilyl)-
propane-sulfonic acid sodium salt (DSS), while 15Na n d
13C chemical shifts were referenced indirectly to a liquid
ammonia and DSS, respectively, based on the absolute
frequency ratios [34].
The comparison between reduced and oxidized forms
of MsrB1 was performed by analyzing 2D 15N-1HH S Q C
spectra of both reduced and oxidized MsrB1. The spectra
were acquired using pulse sequence from the standard pulse
sequencelibrary.N-Hcouplingconstantwassetto90ms,the
relaxation delay in HSQC experiments was of 1s. 2048 com-
plex points were collected in F2 dimension, while 256 were
collected in F1 dimension. 32 scans per each transient have
been recorded.
1H, 13C, and 15N backbone resonance assignments
for Trx protein were achieved using 15N HSQC, HNCA,
CBCA(CO)NH, CBCANH, HBHANH, HBHA(CO)NH,
and 15N NOESY NMR spectra from the standard pulse
sequence library.
The NMR data were processed with the BRUKER XWin-
NMR version 3.5 and Varian VNMRJ version 2.2C software.
Spectral analysis was performed using CARA version 1.8.4.2
[35].
In order to map the interacting sites of both Trx and
MsrB1 proteins, that is, to determine which aminoacids are
involved in the formation of the interprotein complex, NMR
titration of each protein was performed. 15N-1HH S Q C
of 15N labeled oxidized MsrB1 was recorded followed by
acquisition of the series of HSQC spectra of oxidized MsrB1
in the presence of increasing amounts of 15N-unlabeled Trx.
Likewise, the 15N-1HH S Q Cs p e c t r u mo f15N-enriched pure
Trxwasrecordedﬁrst,followedbythesetofHSQCspectraof
Trx containing an increasing amount of unlabeled oxidized
MsrB1.Alltitrationexperimentswerecarriedoutthreetimes
at 298K at two diﬀerent pH values 5.5 and 6.5 in order to
have statistically signiﬁcant results.
2.4. Molecular Modelling. Structural calculations for MsrB1
and Trx and their complex were performed using molecular
modelling techniques, including molecular mechanics and
protein docking (Molsoft ICM Pro 3.6 program package
[36],ECEPP/3forceﬁeld[37])aswellasmoleculardynamics
simulations (GROMACS program package version 4.0.7
[38], G53a6 force ﬁeld [39]). VMD [40]a n dI C MP r o3 . 6
program packages were used to visualize and analyze molec-
ular dynamics (MD) trajectories and the resulting averaged
spatial structures of the proteins and their complexes. The
initial sets of atomic coordinates of the proteins (reduced
forms) were taken from PDB (2kv1 and 3trx for MsrB1 and
Trx, resp.).
MD simulations were carried out using a standard
protocol including the following steps: energy minimization,
water box equilibration, and productive run. Both structures
of MsrB1 protein and four complexes of its oxidized form
with reduced Trx were placed in dodecahedral water box.
The box dimensions were chosen in such a way that water
shell around the protein structures was no less than 12 ˚ A.
Water molecules were represented by SPC model [41]. The
intrinsic MsrB1 positive charge was neutralized with two
Cl− ions, and the negative charge of the protein complex
was neutralized by three Na+ ions. The energy minimization
procedure was executed with steepest descent method. Dur-
ing 300ps equilibration of the water molecules surrounding
protein, spatial position of its atoms was constrained. The
equilibrationprocedurewasfollowedbytwoproductiveruns
with 5ns and 20ns in order to separate proteins and their
complexes, respectively. Distances between Zn2+ ion and Sγ
atoms of the coordinating cysteines of MsrB1 (Cys23, Cys26,
Cys71, and Cys74) were restricted with help of harmonic
potential having a minimum at a value of 2.35 ˚ A. The
averaged molecular structures were obtained by the cluster
analysis [42]a f t e re a c hp r o d u c t i v er u no fM D .
MD integration step was equal to 2fs. LINCS algorithm
[43] was used to constrain the covalent bond distances and
the valence angle values. The temperature of the system was
held at 300K with velocity-rescale algorithm [44]. To hold
system pressure at 1atm value, Berendsen barostate [45]
with the time constant for coupling, τ = 0.5ps was used.
Long-range electrostatics was calculated with PME method
[46]. The cut-oﬀ distance of nonbonded interactions was4 Journal of Biomedicine and Biotechnology
set to 10 ˚ A for van der Waals interactions and to 14 ˚ Af o r
electrostatic interactions.
To obtain the disulﬁde bond between Cys95 and Cys4
residues in oxidized MsrB1, MD simulations in explicit
water box with the described above protocol were used,
except that the distance between Sγ atoms of two cysteines
was restrained at 2.8 ˚ A with the force exceeding van der
Waals repulsion of these atoms. The disulﬁde bond itself
was formed and its geometry was optimized by molecular
mechanic procedures in ECEPP/3 force ﬁeld implemented in
ICMPro3.6programpackage.Toconstructthemutantform
Cys35Ser of Trx, the side chain of the mutated aminoacid
together with its neighbours situated within 5 ˚ Ar a d i u s ,w e r e
subjected to the energy minimization procedure in ECEPP/3
potential. The average structures of oxidized MsrB1 and
reducedTrxhavebeensubsequentlysubjectedtotheprotein-
protein docking in ICM Pro 3.6. This algorithm uses optimal
docking area parameter representing the protein surface
regions with the maximum dehydration energy arising upon
formation of the tight protein-protein contact. To reduce
conformational sampling calculations, only the “hot points”
that were situated near MsrB1 and Trx active sites were used
within the study. Interaction energies were calculated using
potential grids with 0.5 ˚ A cells, and the truncated van der
Waals potential with maximum 1.0kcal/mol was used.
The conformations of MsrB1-Trx complex, obtained
from docking, having a representative distance between Sγ
Cys95 of MsrB1 and Sγ C32 of Trx less than 10 ˚ A, were taken
for further analysis and sorted into four groups depending
on the mutual orientations of the two proteins. Then, the
representative conformations from each of four groups were
reﬁned by the above-described molecular dynamics simula-
tion methods.
3. Results andDiscussion
3.1. Assignment of Oxidized MsrB1. Upon oxidation, MsrB1
undergoes structural changes caused by the intramolecular
Cys95/Cys4 disulﬁde bond formation [25] .I no r d e rt oa s s i gn
1Ha n d15N NMR spectra of the oxidized MsrB1, the HSQC
spectra of MsrB1 protein in both oxidized and reduced states
were compared [25, 47].
This analysis revealed close similarity between the HSQC
spectra of both redoxed forms: the majority of the cross-
peaks assigned in the case of reduced MsrB1 protein re-
mained either at the same position in 1H-15NH S Q Cs p e c t r a
or their positions were slightly altered. This overall spectral
correspondence between reduced and oxidized forms of
MsrB1 allowed us to unambiguously identify and assign the
cross-peaks related to the most of the aminoacids of the
oxidized MsrB1. Nevertheless, the signal broadening and
the shift of some of the cross-peaks in the oxidized protein
corresponding to the residues either belonging to the
protein active site or situated in its vicinity were observed
(Cys4, Phe82, Cys95, and Ile96). The performed comparison
provided us with the assignment of the 1Ha n d15N chemical
shifts of oxidized MsrB1 protein and indicated that no major
structural changes occur in MsrB1 protein upon oxidation.
3.2. Assignment of Reduced Trx. The protein’s backbone
assignment was performed using a standard procedure. The
availability of the assignment of native human Trx (313K,
pH = 5.5) [48] assisted in the obtainment of the present
assignment. As a result, 95% of all Trx aminoacids were
identiﬁed and assigned in the present study. The backbone
assignments of Trx’s 1H, 13C, and 15Nn u c l e iw e r ed e p o s i t e d
in BioMagResBank under accession number BMRB-16850.
The obtained within the study assignments for both oxidized
MsrB1 and reduced Trx provided a basis for our further
investigations on interaction between Trx and MsrB1.
3.3. Monitoring of Interaction of Oxidized MsrB1-Trx. NMR
spectroscopy is a commonly used technique for mapping
the interacting site of a protein upon complex formation
with its ligands. Within the study, it was performed the
NMR titration of oxidized MsrB1 with reduced Trx and vice
versa. To determine whether the interaction of these proteins
can be observed on NMR time scale and, in the positive
case, to determine which aminoacids from those proteins are
involved in the interaction, the following approach was used.
15N-enriched protein (either MsrB1 or Trx) was titrated with
nonenriched partner, and their interaction was monitored
by comparative analysis of 1H-15N HSQC spectra of a single
protein and the protein in the presence of its partner.
Since only one protein was enriched with 15NN M Ra c t i v e
isotope in each single experiment, the presence in solution
of another protein did not hamper the observation of 1H-
15N spectrum under analysis, and it was possible to clearly
identify aminoacids changing their NMR parameters (either
chemicalshifts(shiftingofthecross-peak)orrelaxationrates
(broadening of the cross-peak)), which indicated that these
residues are involved in interaction with another protein.
This analysis allowed us to determine which aminoacids
from each protein are directly involved in the complex
formation.
3.4. The NMR Titration of Oxidized MsrB1 with Reduced
Trx. The titration of MsrB1 revealed its aminoacids involved
in binding with Trx. The integral chemical shift diﬀerences
calculated for all MsrB1 residues using the relationship
Δ1H+Δ15N/7 (Δ1H+Δ15N/5 for glycine residues) [49]a n d
plotted as a function of the aminoacid number, are shown in
Figure 1(a). These data show that the residues belonging to
the MsrB1 active site as well as their neighbouring residues
directly participate in interaction with reduced Trx (C4-F7,
E65, and C95-F97). It was also observed that the MsrB1
HSQC cross peaks corresponding to the residues revealing
the maximal shifts upon interaction with Trx became broad-
er (increase of transverse relaxation rates), thus supporting
our ﬁnding in pinpointing of the interaction relevant ami-
noacids. Altogether, our studies indicate that these MsrB1
residues are involved in protein complex formation with Trx.
3.5. The NMR Titration of Reduced Trx with Oxidized MsrB1.
The integral 1H-15N HSQC chemical shift diﬀerences for
all Trx residues plotted as a function of the aminoacid
number were obtained as described above and are shown inJournal of Biomedicine and Biotechnology 5
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Figure 1:(a)ChemicalshiftdiﬀerenceobservedforeachresidueofMsrB1uponNMRtitrationbyTrx.Lowerpanelshowsinredtheresidues
belonging to the protein active site revealing maximal changes upon titration. (b) The 3D structure of oxidized mammalian MsrB1. “Hot
points” used for molecular docking are evidenced in red.
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Figure 2:(a)ChemicalshiftdiﬀerenceobservedforeachresidueofTrxuponNMRtitrationbyMsrB1.Lowerpanelshowsinredtheresidues
revealing maximal changes upon titration. (b) The 3D structure of oxidized mammalian Trx. “Hot points” used for molecular docking are
evidenced in red.
Figure 2(a).ThetitrationofTrxhasrevealedthreeaminoacid
areaswhichareinvolvedininteractionwithMsrB1:D26-S35,
V57-E68,andK72-M74.Thesesegmentsareevidencedinred
on the lower panel of Figure 2(a). Our results indicate that:
(i) Trx active site (as expected) is involved in the interaction;
(ii) the monitored segments are situated mostly on the Trx
external loops; (iii) these segments are rather close in space,
thus supporting and validating our ﬁndings.
3.6. Structural Modelling of Oxidized MsrB1 and Reduced
Trx. The average structures of oxidized MsrB1 and reduced
Trx were obtained from the molecular dynamics simulations
starting from coordinates of the reduced proteins taken from
PDB(2kv1and3trxforMsrB1andTrx,resp.).Thecalculated
structures are shown in Figures 1(b) and 2(b).
3.7. Docking of Oxidized MsrB1 and Trx. Upon formation of
an intermolecular protein complex, catalytic Cys32 (active
residue) and Cys35 (resolving residue) of Trx should become
close in space to the disulﬁde bond, connecting Cys4 and
Cys95 residues of oxidized MsrB1. Such arrangement makes
possible that Cys32 of Trx attacks the MsrB1 disulﬁde bond.
A protein docking procedure was carried out in order to
identify possible options for mutual arrangement of these
proteins. Based on the above-mentioned distance restrains
and experimental NMR data, the “hot points of docking”,
were found (evidenced for both proteins in Figures 1(b)
and 2(b) in red), and more than 1000 spatial structure
orientations were generated. Our experimental data on
residues involved in complex formation and application of
10 ˚ A distance restrains between the Sγ atoms of Cys32 of Trx6 Journal of Biomedicine and Biotechnology
Table 1: Structural parameters for MsrB1-Trx complexes (four groups) revealed by protein docking. The distances between sulphur atom
of Cys32 of Trx and the nearest sulphur atom of MsrB1 disulﬁde bond as well as three pairs of the nearest aminoacids approaching in space
for each group (to outline the spatial orientation of the proteins within a complex) are presented.
Group A Group B Group C Group D
Distance, ˚ A (Trx Cys32)
S/S–S bond (MsrB1)
7,1 7,8 7,8 5,3
Nearest neighbouring contacts between residues
MsrB1 residues W43 H39 P87 S2 W43 P87 W43 N62 P87 F6 P42 R93
Trx residues M37 E95 S90 W31 A92 E70 M37 K72 K96 K72 D60 K36
(A) (B) (C)
(a) (b) (c)
C
C
C
N-term
R93
I96
N-term
S5
I96 F7
S98
Figure 3: The snapshots (A, B, and C) of the protein complex formation along the molecular dynamics trajectory. The panels (a), (b), and
(c) show zoomed views (interactions interfaces) of the snapshots (A) and (C), respectively.
and Cys4-Cys95 disulﬁde bond of MsrB1 were used to sort
these structures into four groups. The neighbouring contacts
between residues and the distances between sulphur atom of
Cys32 (Trx) and the nearest sulphur atom of oxidized MsrB1
disulﬁde bond, diﬀerentiating each group, are shown in
Table 1.
Among the four represented complexes, the fourth (D) is
the most plausible since the distance in this structure be-
tween Cys32 of Trx, and two sulphur atoms of disulﬁde bond
in MsrB1 were found to be minimal (5.3 ˚ A). Further, each of
the four representative structures has been subjected to 5ns
molecular dynamics simulations.
3.8. Molecular Dynamics Procedure. The aim of the molecu-
lar dynamics simulation was to reﬁne the possible structure
of the Trx-MsrB1 complex taking into account the obtained
NMR data, the eﬀects of water environment, and ﬂexibility
of proteins backbone and side chains. The analysis of the
averaged structures of the complexes obtained after 5ns
of MD simulations reveal that only for complex D the
distance SγCys32 Trx–SγCys4 MsrB1 remains the smallest
among all possible complexes. Therefore, the MD trajectory
f o rt h i sc o m p l e xw a se x t e n d e dt o2 0 n s( F i g u r e s3(a) and
3(c)). It is necessary to emphasize that even if these data
suggest that the SγCys32 Trx is closer to SγCys4 of oxidized
MsrB1, the analogous distance to Cys95 is rather compa-
rable. This observation precludes us to determine which
Cys residue from intramolecular MsrB1 disulﬁde bridge will
be subsequently targeted to form intermolecular disulﬁde
bond.Journal of Biomedicine and Biotechnology 7
As it was calculated by our MD, the N-terminal tail of
MsrB1 upon oxidation gets closer to the β-strand of the pro-
tein formed by Arg93-Ile96 (Figures 3(A) and 3(a)). Fur-
ther, elongation of the mentioned MsrB1’s β-strand occurs
additionally involving residues I96-S98 accompanied by
formation of three additional hydrogen bonds with residues
S5-F7 (Figures 3(B) and 3(b)). This newly constituted strand
belongs to the N-terminus of MsrB1, which now is stabilized
by the intramolecular disulﬁde bond formed upon oxida-
tion. At the ﬁnal stage of the interaction, Trx adjusts its
unstructured loop to the newly formed N-terminal β-strand
of MsrB1, leading to formation of interprotein β-sheet,
composed of six β-strands, where ﬁve of them belong to
MsrB1 and the sixth to Trx (residues K72-M74) (Figures
3(C) and 3(c)). Thus, in developing of two new β-strands
(one intramolecular MsrB1 and one intermolecular), nine
aminoacids participate. This observation is in good agree-
ment with our NMR titration results (Figures 1 and 2), thus
further validating our calculations. In addition, β-strand of
MsrB1 formed by G77-F82 extends periodically to residues
G75-G77 allowing residues G75-L78 to form hydrogen
bonds with the second antiparallel β-strand of MsrB1
constituted by A66-G72. The distance between SγCys32 of
thioredoxin and SγCys95 of MsrB1, a reference distance,
oscillates during the interaction from the smallest value of
about 3.2 ˚ A (ﬁrst 100ps of the trajectory) to 9.5 ˚ A and then
down to 4.8 ˚ A. Such approaching may cause a catalytic act,
upon which the disulﬁde bond becomes resolved followed by
reduction of MsrB1.
Upon the formation of the protein intermolecular com-
plex, six new hydrogen bonds evolve (three of them are
interproteins), thus stabilizing the intermolecular complex.
Analysis of MD trajectories for MsrB1-Trx complex (prior
formation of the intermolecular disulﬁde bond) indicates
an existence of two conformations of C4-C95 MsrB1 bond.
The disulﬁde bond in both conformations is strained in
diﬀerent extent. The degree of strain could be estimated by
comparison of the energies for the van der Waals (vw) and
torsion(to)termsofdisulﬁdebondforoxidizedMsrB1inthe
stepprecedingthecomplexformationandinthefreestate.In
accordance with ECEPP/3 force ﬁeld, the following energies
have been obtained (kcal/mol): 3.1 and 3.2 (vw), −0.5 and
−1.7 (to), 2.6 and 1.5 (total) for “strained” and “relaxed” S–
S bond, respectively. It is worth to mention that during the
MD simulations this MsrB1 intramolecular S–S bond prefers
its “strained” conformation. This bond thus becomes totally
destabilized by 2.6kcal/mol for “strained” or by 1.5kcal/mol
for “relaxed” conformation. However, the presence of six
hydrogen bonds inside the developed interprotein β-sheet
obviously overcompensates the straining of Cys4-Cys95
bond in MsrB1, as energy proﬁt from one hydrogen bond
formation in β-sheet can be estimated by −0.78kcal/mol
[50].Therefore,theformationoftheinterproteinMsrB1-Trx
complex becomes energetically preferable.
4. Conclusions
In this study, both the experimental and the computational
approaches were combined to investigate MsrB1-Trx protein
complex formation. Through the analysis of the NMR data,
the aminoacids involved in protein complex formation have
been determined. The average 3D structures of oxidized
MsrB1 and reduced Trx were generated and subsequently
subjected to protein docking and molecular dynamics. Com-
plementary use of the mentioned approaches indicates that
the formation of the interprotein β-sheet, stabilized by new
hydrogen bonds, distorting the MsrB1 intramolecular disul-
ﬁde bond. This disulﬁde bond straining favours the forma-
tion of intermolecular disulﬁde bridge of MsrB1-Trx com-
plex. The study evidences structural and energetic driving
forces of MsrB1-Trx complex formation.
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